Skip to the page

Data / Federal grants / HT942526RCRPRCDA

DoW Rare Cancers Resource and Community Development Award

Defense Health Agency Contracting Activity - DHACA (Department of Defense) is accepting applications until November 18, 2026. It lists 5 awards expected, $5.6 million in total.

SpecStream is the live web data engine for teams and agents. It reads every open and forecast federal opportunity on Grants.gov each morning, and this page is that reading. Describe your organization once and the grants that fit arrive in your sheet, CRM, Slack or agent as they are posted.

Key facts

Opportunity number
HT942526RCRPRCDA
Status
Posted, open
Posted
June 17, 2026
Closes
November 18, 2026
Expected awards
5
Total funding
$5,600,000
Cost sharing
Not required
Funding instrument
Grant
Category
Science and Technology and other Research and Development
Assistance listing
12.420 Military Medical Research and Development
Contact
JoAnn Martin Grantor · [email protected] · 301-619-2594

Who can apply

  • Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

What the agency says

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources and clinical or preclinical datasets that will advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. Research supporting this funding opportunity should fill one of the following major gaps: Lack of research and clinical resources, including patient tissues, cell and tumor models. Lack of communication and dissemination strategies within scientific and patient communities for sharing rare cancers research and clinical findings. Lack of infrastructure for sharing data and other resources. Lack of therapeutics and mechanistic research to inform treatment development.

Distinctive Features: Documentation of plans for engagement and partnerships with Patient Advocates throughout the life cycle of the research study from development of the research question through execution of the study. Community building and enhancement are key components. A description of the dissemination and sustainability of the platform for scientific and/or clinical and patient community is required. Preliminary data are not required but may be included to address feasibility.

The notice on Grants.gov

Other open grants from the Department of Defense

All grants open to Anyone (unrestricted) · Everything closing in November 2026

Read from the Grants.gov API, last updated 2026-10-23. The agency's notice on Grants.gov is the official record; check it before you apply.